Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Julian A. Gray"'
Autor:
Michael S. Rafii, Olivier Sol, William C. Mobley, Saskia Delpretti, Brian G. Skotko, Anna D. Burke, Marwan N. Sabbagh, Shauna H. Yuan, Robert A. Rissman, Margaret Pulsifer, Casey Evans, A. Carol Evans, Gregory Beth, Nicolas Fournier, Julian A. Gray, Antonio Melo dos Santos, Valerie Hliva, Marija Vukicevic, Marie Kosco-Vilbois, Johannes Streffer, Andrea Pfeifer, Howard H. Feldman
Publikováno v:
JAMA Neurol
IMPORTANCE: Individuals with Down syndrome (DS) are at high risk of developing Alzheimer disease due to an increased dose of the amyloid precursor protein gene, APP, which leads to increased levels of full-length APP and its products, including amylo
Autor:
Olivier Sol, Bénédicte Lê, Elena Valatsou, Saskia Delpretti, Julien Rongere, Marija Vukicevic, Julian JG Gray, Valerie Hliva, Marie Kosco‐Vilbois, Andrea Pfeifer, Johannes Streffer
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Michael S Rafii, Olivier Sol, William C Mobley, Brian G. Skotko, Anna D Burke, Marwan N. Sabbagh, Shauna Yuan, Robert A. Rissman, Saskia Delpretti, Greg Beth, Julian JG Gray, Antonio Melo dos Santos, Valerie Hliva, Marija Vukicevic, Marie Kosco‐Vilbois, Johannes Streffer, Andrea Pfeifer, Howard Feldman
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
Journal of Chemical Neuroanatomy. 104:101748
Playing a musical instrument requires fast multimodal sensory-motor processing which can be activated by voluntary access to performance imagery. Musicians use different methods to activate imagery for the purpose of “mental practice”. The aim of
Publikováno v:
Rocks & Minerals. 91:209-211
Autor:
Robert B. Cook, Julian C. Gray
Publikováno v:
Rocks & Minerals. 89:214-223
Although famous for its historical gold production, Georgia has few gold specimens with acceptable attribution in existence today. These specimens occur as nuggets or masses of gold derived from pl...
Publikováno v:
Alzheimer's Research & Therapy
An important factor in the universal failure in phase III trials in mild to moderate Alzheimer’s disease in the past decade is the lack of phase II clinical data prior to entering phase III, with common reliance on biomarker results alone. Conducti
Publikováno v:
Rocks & Minerals. 89:211-213
Autor:
Julian A. Gray
Publikováno v:
Drug Information Journal. 33:245-252
The current state of clinical trial methodology in Alzheimer’s disease is discussed. With the development of regulatory guidelines and experience with cholinergic drugs in recent years there has been considerable progress in this field, especially
Autor:
Julian C. Gray, Theodore J. Bornhorst
Publikováno v:
Rocks & Minerals. 90:211-211